Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 547-553

  Feng, Qinghua ^a,c   Cherne, Stephen ^a   Winer, Rachel L ^b   Balasubramanian, Akhila ^b   Lee, Shu Kuang ^b   Hawes, Stephen E ^b   Kiviat, Nancy B ^a   Koutsky, Laura A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS CULTURE; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MICROARRAY ANALYSIS; MICROSPHERES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 62749096022     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01707-08     Document Type: Article

References (31)

1. ASCUS-LSIL Triage Study (ALTS) Group. 2003. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 188:1383-1392.
2. Baseman, J. G., and L. A. Koutsky. 2005. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32(Suppl. 1):S16-S24.
3. Castle, P. E., P. E. Gravitt, D. Solomon, C. M. Wheeler, and M. Schiffman. 2008. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study. J. Clin. Microbiol. 46:109-117.
4. Castle, P. E., C. Porras, W. G. Quint, A. C. Rodriguez, M. Schiffman, P. E. Gravitt, P. Gonzalez, H. A. Katki, S. Silva, E. Freer, L.-J. Van Doorn, S. Jiménez, R. Herrero, and A. Hildesheim for the CVT Group. 2008. Comparison of two PCR-based human papillomavirus genotyping methods. J. Clin. Microbiol. 46:3437-3445.
5. Dunn, S. T., R. A. Allen, S. Wang, J. Walker, and M. Schiffman. 2007. DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J. Virol. Methods 143:45-54.
6. Gravitt, P. E., and R. Jamshidi. 2005. Diagnosis and management of oncogenic cervical human papillomavirus infection. Infect. Dis. Clin. N. Am. 19:439-458.
7. Gravitt, P. E., C. L. Peyton, R. J. Apple, and C. M. Wheeler. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
8. Gravitt, P. E., M. Schiffman, D. Solomon, C. M. Wheeler, and P. E. Castle. 2008. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol. Biomarkers Prev. 17:1248-1254.
9. Han, J., D. C. Swan, S. J. Smith, S. H. Lum, S. E. Sefers, E. R. Unger, and Y. W. Tang. 2006. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J. Clin. Microbiol. 44:4157-4162.
10. Harper, D. M., E. L. Franco, C. Wheeler, D. G. Ferris, D. Jenkins, A. Schuind, T. Zahaf, B. Innis, P. Naud, N. S. De Carvalho, C. M. Roteli-Martins, J. Teixeira, M. M. Blatter, A. P. Korn, W. Quint, and G. Dubin. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757-1765.
11. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, et al. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
12. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
13. Jiang, H. L., H. H. Zhu, L. F. Zhou, F. Chen, and Z. Chen. 2006. Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J. Med. Microbiol. 55:715-720.
14. Kiviat, N. B., S. E. Hawes, and Q. Feng. 2008. Screening for cervical cancer in the era of the HPV vaccine - the urgent need for both new screening guidelines and new biomarkers. J. Natl. Cancer Inst. 100:290-291.
15. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
16. Kulasingam, S. L., J. P. Hughes, N. B. Kiviat, C. Mao, N. S. Weiss, J. M. Kuypers, and L. A. Koutsky. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288:1749-1757.
17. Liu, M., C. X. Wang, X. M. Deng, L. S. Wang, J. Zhang, W. Li, G. X. Zheng, and J. F. Wang. 2007. Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province. Zhonghua Liu Xing Bing Xue Za Zhi. 28:487-490. (In Chinese.)
18. Manos, M. M., Y. Ting, D. K. Wright, A. J. Lewis, T. R. Broker, and S. M. Wolinsky. 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus, p. 209-214. In M. Furth and M. Greaves (ed.), Molecular diagnostics of human cancer, vol. 7. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Monsonego, J., F. X. Bosch, P. Coursaget, J. T. Cox, E. Franco, I. Frazer, R. Sankaranarayanan, J. Schiller, A. Singer, T. C. Wright, Jr., W. Kinney, C. J. Meijer, J. Linder, E. McGoogan, and C. Meijer. 2004. Cervical cancer control, priorities and new directions. Int. J. Cancer 108:329-333.
20. Muñoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsagué, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
21. Muñoz, N., X. Castellsagué, A. B. de González, and L. Gissmann. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24(Suppl. 3):S1-S10.
22. Oh, Y., S. M. Bae, Y. W. Kim, H. S. Choi, G. H. Nam, S. J. Han, C. H. Park, Y. Cho, B. D. Han, and W. S. Ahn. 2007. Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci. 98:549-554.
23. Paraskevaidis, E., M. Arbyn, A. Sotiriadis, E. Diakomanolis, P. Martin-Hirsch, G. Koliopoulos, G. Makrydimas, J. Tofoski, and D. H. Roukos. 2004. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat. Rev. 30:205-211.
24. Peyton, C. L., P. E. Gravitt, W. C. Hunt, R. S. Hundley, M. Zhao, R. J. Apple, and C. M. Wheeler. 2001. Determinants of genital human papillomavirus detection in a US population. J. Infect. Dis. 183:1554-1564.
25. Sabol, I., M. Salakova, J. Smahelova, M. Pawlita, M. Schmitt, N. M. Gasperov, M. Grce, and R. Tachezy. 2008. Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J. Clin. Microbiol. 46:1606-1613.
26. Schmitt, M., I. G. Bravo, P. J. Snijders, L. Gissmann, M. Pawlita, and T. Waterboer. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512.
27. Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. E. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. J. Kurman, B. M. Ronnett, M. H. Stoler, A. Ferenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6:271-278.
28. Wallace, J., B. A. Woda, and G. Pihan. 2005. Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J. Mol. Diagn. 7:72-80.
29. Weaver, B. A., Q. Feng, K. K. Holmes, N. Kiviat, S. K. Lee, C. Meyer, M. Stern, and L. A. Koutsky. 2004. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J. Infect. Dis. 189:677-685.
30. Winer, R. L., J. P. Hughes, Q. Feng, S. O'Reilly, N. B. Kiviat, K. K. Holmes, and L. A. Koutsky. 2006. Condom use and the risk of genital human papillomavirus infection in young women. N. Engl. J. Med. 354:2645-2654.
31. Wright, T. C., Jr., M. Schiffman, D. Solomon, J. T. Cox, F. Garcia, S. Goldie, K. Hatch, K. L. Noller, N. Roach, C. Runowicz, and D. Saslow. 2004. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol. 103:304-309.